Literature DB >> 31611966

Long non-coding RNA transcribed from pseudogene PPIAP43 is associated with radiation sensitivity of small cell lung cancer cells.

Shilong Wang1,2, Jinming Yu2,3.   

Abstract

Small cell lung cancer (SCLC) is a highly lethal disease. Although radiation therapy is effective for the majority of patients with SCLC, patient sensitivity to radiation varies. The lack of biomarkers impedes advances in targeting radiation-sensitive patients. In this study, the changes in transcription patterns of SCLC cell lines were evaluated with or without 2 Gy gamma radiation. The results demonstrated that peptidyl-prolyl cis-trans isomerase A pseudogene 43 (PPIAP43) transcription was increased 2-fold in cells irradiated with 2 Gy gamma radiation compared with unirradiated cells in pre-reported radio-sensitive sensitive cell lines H69, H128, H146, H209 and H187. These cells shared 259 upregulated and 96 downregulated RNA transcripts following radiation. Pre-reported less sensitive cell lines H526, D53, D114 and D153 in which PPIAP43 was not upregulated 2-fold following irradiation with 2 Gy gamma radiation compared with unirradiated cells, shared 3 upregulated and 9 downregulated RNA transcripts. The RNA transcript of PPIAP43 was aligned with the mRNA of peptidyl-prolyl cis-trans isomerase A (PPIA) at 2 sections (3,732 to 3,917 and 5,327 to 5,657 of the PPIA gene) and the sequences were shown to be 96 and 94% similar, respectively. Therefore, PPIAP43 may act as a sponge for microRNAs which bind with the RNA of PPIA. Therefore, PPIAP43 RNA transcription may serve as a potential biomarker of radio-sensitivity of SCLC.
Copyright © 2019, Spandidos Publications.

Entities:  

Keywords:  Cyclophilin A; PPAP43; potential biomarker; radiation sensitivity; small cell lung cancer cell lines

Year:  2019        PMID: 31611966      PMCID: PMC6781671          DOI: 10.3892/ol.2019.10806

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.

Authors:  Da Wei Huang; Brad T Sherman; Richard A Lempicki
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

2.  A microRNA screen to identify modulators of sensitivity to BCL2 inhibitor ABT-263 (navitoclax).

Authors:  Lloyd T Lam; Xin Lu; Haichao Zhang; Rick Lesniewski; Saul Rosenberg; Dimitri Semizarov
Journal:  Mol Cancer Ther       Date:  2010-09-09       Impact factor: 6.261

3.  MiR-876-5p acts as an inhibitor in hepatocellular carcinoma progression by targeting DNMT3A.

Authors:  Yizhou Wang; Yanting Xie; Xifeng Li; Jianbo Lin; Shichao Zhang; Zheng Li; Lei Huo; Renyan Gong
Journal:  Pathol Res Pract       Date:  2018-04-21       Impact factor: 3.250

Review 4.  The role of radiotherapy in lung cancer: where is the evidence?

Authors:  Jacek Jassem
Journal:  Radiother Oncol       Date:  2007-05-04       Impact factor: 6.280

5.  Cyclophilin A is secreted by a vesicular pathway in vascular smooth muscle cells.

Authors:  Jun Suzuki; Zheng-Gen Jin; David F Meoli; Tetsuya Matoba; Bradford C Berk
Journal:  Circ Res       Date:  2006-03-09       Impact factor: 17.367

6.  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.

Authors:  Laura Poliseno; Leonardo Salmena; Jiangwen Zhang; Brett Carver; William J Haveman; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

7.  miRDB: an online resource for microRNA target prediction and functional annotations.

Authors:  Nathan Wong; Xiaowei Wang
Journal:  Nucleic Acids Res       Date:  2014-11-05       Impact factor: 16.971

Review 8.  Cyclophilin A: a key player for human disease.

Authors:  P Nigro; G Pompilio; M C Capogrossi
Journal:  Cell Death Dis       Date:  2013-10-31       Impact factor: 8.469

9.  Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer.

Authors:  Taofeek K Owonikoko; Guojing Zhang; Xingming Deng; Michael R Rossi; Jeffrey M Switchenko; Gregory H Doho; Zhengjia Chen; Sungjin Kim; Sandy Strychor; Susan M Christner; Jan Beumer; Chunyang Li; Ping Yue; Alice Chen; Gabriel L Sica; Suresh S Ramalingam; Jeanne Kowalski; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Med       Date:  2014-08-13       Impact factor: 4.452

10.  Correlation between the Ki-67 proliferation index and response to radiation therapy in small cell lung cancer.

Authors:  Naoya Ishibashi; Toshiya Maebayashi; Takuya Aizawa; Masakuni Sakaguchi; Haruna Nishimaki; Shinobu Masuda
Journal:  Radiat Oncol       Date:  2017-01-13       Impact factor: 3.481

View more
  3 in total

1.  Pseudogenes as Biomarkers and Therapeutic Targets in Human Cancers.

Authors:  Cristina Sisu
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Cancer, Retrogenes, and Evolution.

Authors:  Klaudia Staszak; Izabela Makałowska
Journal:  Life (Basel)       Date:  2021-01-19

Review 3.  Not So Dead Genes-Retrocopies as Regulators of Their Disease-Related Progenitors and Hosts.

Authors:  Joanna Ciomborowska-Basheer; Klaudia Staszak; Magdalena Regina Kubiak; Izabela Makałowska
Journal:  Cells       Date:  2021-04-15       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.